Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma

SIMPLE SUMMARY: Patients with glioblastoma have a dismal prognosis. The major challenge with this disease is that it recurs despite aggressive first-line therapy and rapidly becomes therapy resistant. Cytomegalovirus has been found in most glioblastoma tumors and may contribute to tumor aggressivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantalone, Mattia Russel, Rahbar, Afsar, Söderberg-Naucler, Cecilia, Stragliotto, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030820/
https://www.ncbi.nlm.nih.gov/pubmed/35454863
http://dx.doi.org/10.3390/cancers14081958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030820/
https://www.ncbi.nlm.nih.gov/pubmed/35454863
http://dx.doi.org/10.3390/cancers14081958

Ejemplares similares